• Acne

    The main signs of Acne vulgaris are areas of scaly red skin (seborrhea), blackheads and whiteheads (comedones), and inflammatory lesions or pimples, such as pinheads (papules), nodules (large papules) and pustules, as well as cysts, and possible scarring.

    The purpose of this study is to evaluate the efficacy of topical study medication compared to placebo in treating inflammatory acne lesions in subjects with moderate to severe facial acne vulgaris.

    Duration:  12 weeks.

    Number of visits:  5 office visits.

    Compensation:  $400 for completing the study.

    Qualified participants: Must be between 9 or older and have moderate to severe facial acne vulgaris.

  • Osteoarthritis of the Knee

    Osteoarthritis of the Knee – Arthritis means “joint inflammation.” It causes pain and swelling in the body’s joints, such as the knees. There are many types of arthritis; osteoarthritis is more likely to develop as people get older.

    The purpose of this study The objective of this study is to determine the efficacy, safety, and tolerability of the study drug in the treatment of knee osteoarthritis (OA).

    Duration:  56 weeks.

    Number of visits:  9 office visits.

    Compensation:  $875

    Qualified participants: Must be 40 to 80 years old and have moderate to severe Osteoarthritis (OA) of the knee.

  • Plaque Psoriasis

    Plaque Psoriasis is the most common form of the disease and appears as raised, red patches covered with a silvery white buildup of dead skin cells or scale.  These patches or plaques most often appear on the scalp, knees, elbows and lower back.  They are often itchy and painful, and they can crack and bleed.

    The purpose of this study is to assess the efficacy of the study medication for the treatment plaque psoriasis.

    Duration:  4 weeks.

    Number of visits:  3 office visits.

    Compensation:  $195 for completing the study.

    Qualified participants: Must be 18 to 80 years of age and have severe itching due to plaque psoriasis.

  • Low Testosterone

    Clinical Research Study for Cardiovascular
    Disease or Peripheral Vascular Disease with Low Testosterone.

    To qualify you must be:

    • Male
    • 45 – 80

    Have or have had one of the following:

    • Heart Attack
    • Cardiovascular Disease
    • Stroke
    • Peripheral Vascular Disease (PVD)

    You also need to have Low Testosterone to join our clinical research study.

    Purpose of the study:  is to compare the effect of the study medication and placebo on the incidence of major adverse medical event (mace) in middle-age and older men with Low-T who are at risk for cardiovascular disease.

    Duration:  60 Months

    Number of visits:  17 office visits and 10 phone calls.

    Compensation:  $1290.00 for completing the study.

  • Osteoarthritis of the Hip

    Osteoarthritis of the Hip– Arthritis means “joint inflammation.” It causes pain and swelling in the body’s joints, such as the knees or hips.  There are many types of arthritis; osteoarthritis is more likely to develop as people get older.

    The purpose of this study is to assess the efficacy of the study medication on pain following an intra-articular (IA) injection in patients with hip osteoarthritis (OA).

    Duration:  36 weeks.

    Number of visits:  13 office visits.

    Compensation:  $750 for completing the study.

    Qualified participants: Must be 40 to 80 years of age and have a diagnoses of osteoarthritis (OA) of the hip.

  • OAB in men with Benign Prostatic Hyperpasia (BPH)

    OAB in men with Benign Prostatic Hyperpasia (BPH) – OAB is a condition characterized by the sudden urge to urinate, with or without accidental urinary leakage, and usually with increased frequency. OAB associated with BPH in male patients has not been extensively studied.  Often in these patients, OAB symptoms remain inadequately addressed despite treatment for their BPH.

    The purpose of this study is to find out if the study drug is effective, safe, and tolerated in men with OAB symptoms while taking medication for BPH.

    Duration:  27 weeks.

    Number of visits:  11 office visits.

    Compensation:  $980 for completing the study.

    Qualified participants: Males 45 years and older who have OAB symptoms and are being treated for BPH.